BOULDER HILL CAPITAL MANAGEMENT LP Halozyme Therapeutics, Inc. Transaction History

BOULDER HILL CAPITAL MANAGEMENT LP portfolio value:

$755,000
portfolio value

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 19.1K shares 755K $39.54 19.1K